Targeted Cancer Therapy: Class Related Toxicities

Conn Med. 2015 Feb;79(2):109-13.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / classification
  • ErbB Receptors / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Humans
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Vascular Endothelial Growth Factor A
  • MTOR protein, human
  • ErbB Receptors
  • Fusion Proteins, bcr-abl
  • TOR Serine-Threonine Kinases